EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Value of the Inflammatory Burden Index in the Diagnosis and Prognosis of Subacute Thyroiditis

Sumei Wang, Jing Lu, Rui Guo, Xueyang Wang, Bijun Tong, Yan Shen, Hongxiang Xie

Endocrinology and Metabolism · 31.10.2026 · 41 (5) · 671-685

DOI: 10.3803/enm.2025.2642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.10.2026. Verfasst von Sumei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical …. Hauptthemen laut MEDLINE: Thyroiditis, Subacute, Graves Disease, Inflammation, Biomarkers. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China-Shandong Joint Fund, Zhejiang Province Traditional Chinese Medicine Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study sought to assess the utility of the inflammatory burden index (IBI) in differentiating subacute thyroiditis (SAT) from Graves’ disease (GD) and to investigate its association with recovery time, hepatic function impairment, recurrence, and permanent hypothyroidism in patients with SAT.

Methods

Clinical and laboratory data from 357 adult patients with SAT, 412 patients with GD, and 633 healthy controls were retrospectively analyzed. Determinants influencing recovery time, hepatic function impairment, recurrence, and permanent hypothyroidism in patients with SAT were systematically evaluated.

Results

The IBI in the SAT cohort was markedly higher than that observed in both patients with GD and healthy controls. Receiver operating characteristic curve analysis indicated that the optimal IBI cutoff value for distinguishing SAT from GD was 9.13, yielding a diagnostic sensitivity of 90.76%, a specificity of 88.35%, and an area under the curve (AUC) of 0.944 (95% confidence interval, 0.927 to 0.961). The AUC for IBI was markedly superior to those for erythrocyte sedimentation rate (ESR), C-reactive protein, systemic immune-inflammation index, and other complete blood count-derived indices. Among patients with painless SAT, the IBI was markedly elevated compared with that in thyroid-stimulating hormone receptor antibody (TRAb)-negative GD patients. Stepwise multiple logistic regression identified ESR, IBI, free thyroxine, and thyroid-stimulating hormone as independent predictive factors for SAT. IBI was not associated with recovery time in patients with SAT. However, higher IBI values were observed in patients requiring glucocorticoid therapy due to an insufficient response to non-steroidal anti-inflammatory drugs. Furthermore, no significant associations were identified between IBI and hepatic function impairment, recurrence, or permanent hypothyroidism in patients with SAT.

Conclusion

IBI, as a simple and practical inflammatory biomarker, could potentially serve as a valuable diagnostic tool for differentiating SAT, particularly in diagnostically challenging cases. Moreover, it may have clinical relevance in guiding therapeutic decision- making for patients with SAT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroiditis, SubacuteGraves DiseaseInflammationBiomarkersHumansFemaleMaleAdultRetrospective StudiesPrognosisMiddle AgedDiagnosis, DifferentialROC CurveCase-Control StudiesC-Reactive ProteinHypothyroidism

Stichwörter der Autor:innen

Blood count-derived indicesGraves diseaseHypothyroidismInflammatory burden indexRecurrenceSubacute thyroiditis

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
  • Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China. guorui@sdhospital.com.cn.
  • Department of Endocrinology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Laboratory, Jinhua Municipal Central Hospital, Jinhua, China.
  • Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China. xiehongxiang007@163.com.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Foundation of China-Shandong Joint Fund
  • Zhejiang Province Traditional Chinese Medicine Science and Technology Program
  • Department of Education of Zhejiang Province
  • Zhejiang Province Medical and Healthy Science and Technology Projects
  • Scientific Research Fund of Zhejiang Provincial Education Department

Zitieren

APA

Wang, S., Lu, J., Guo, R., Wang, X., Tong, B., Shen, Y., & Xie, H. (2026). Value of the Inflammatory Burden Index in the Diagnosis and Prognosis of Subacute Thyroiditis. Endocrinology and Metabolism, 41(5), 671-685. https://doi.org/10.3803/enm.2025.2642

Vancouver

Wang S, Lu J, Guo R, Wang X, Tong B, Shen Y, et al. Value of the Inflammatory Burden Index in the Diagnosis and Prognosis of Subacute Thyroiditis. Endocrinology and Metabolism. 2026;41(5):671-685. doi:10.3803/enm.2025.2642

BibTeX
@article{Wang2026,
  author = {Wang, Sumei and Lu, Jing and Guo, Rui and Wang, Xueyang and Tong, Bijun and Shen, Yan and Xie, Hongxiang},
  title = {Value of the Inflammatory Burden Index in the Diagnosis and Prognosis of Subacute Thyroiditis},
  journal = {Endocrinology and Metabolism},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {671--685},
  doi = {10.3803/enm.2025.2642}
}
Kostenlos starten →